Clinical science

Clinical science

Medicine is not only a science; it is also an art. It does not consist of compounding pills and plasters; it deals with the very processes of life, which must be understood before they may be guided. Paracelsus.

Clinical Science overarches all working groups at IMMEDIAB. Represented by medical doctors (M.D.) who have both a clinical care activity and are involved in research projects supporting work at all levels in the IMMEDIAB LAB. Our clinical scientists work in two diabetology departments in Paris’ largest hospitals (affiliated to the Public Hospitals of Paris; APHP). Both leading University Hospitals: Bichat-Claude-Bernard and Lariboisière. Together, these departments represent the most important clinical care units dedicated to diabetes care in France. Most importantly, our clinicians do not only treat and study diabetes, but all its associated co-morbidities and complications. Our University Centre for Diabetes and its Complications brings all necessary clinical specialists to the patient with diabetes, providing integrated and specialised care on-site.

The tight relationship between clinical partners and research teams allows a strong translational aspect at IMMEDIAB LAB and the efficient return from bench-to-bedside, testing back hypotheses driven by preclinical modelling and vice versa.

Key facts

Cohorts & banking: Numerous consolidated and on-going clinical cohorts (D.E.S.I.R., DIABHYCAR, AgioSafe-T2D, SFDT1, GLUCOGEN, EpiTherapy, BariaGen…) including follow-up studies, up to 10 years.

Human resources:
9 medical doctors,
2 clinical research assistants,
More than 30 nurses over both practices

Clinical trials: Participation in numerous clinical trials supported by both academic (INSERM) and industrial (Novo Nordisk, Sanofi, Bayer, Servier, AstraZeneca) sectors.

Participation in industrial and academic clinical trials in collaboration with industrial companies (Novo Nordisk, Sanofi, Bayer,….)

Clinical staff are a crucial link between link research and patient care